| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |